Biotech · Private company
BlueSphere Bio, Inc
Track this companyFree. Adds BlueSphere Bio, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SOC + BSB-1001 Dose Escalation CohortPhase 2 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- SOC+BSB-1001 Expansion DosePhase 2 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- SOC+ BSB-2002Phase 1 · AML - Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 MutationPHASE1 · WITHDRAWN · started Apr 21, 2026ClinicalTrials.gov NCT07566585 · fetched Nov 12, 2026
- BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDSPHASE1_PHASE2 · TERMINATED · started Feb 4, 2025ClinicalTrials.gov NCT06704152 · fetched Nov 12, 2026